Summary
Interactive effects of combined treatment with hyperthermia and chemotherapeutic agents were interpreted in the experimental aspects of medical science. A survey of the literature and our own studies indicate that cytotoxicity of alkylating agents, cisplatin, bleomycin, and mitomycin C (MMC) can be enhanced at elevated temperatures. However, the thermal enhancement of doxorubicin (Dox) is complicated or even doubtful against tumors, because Dox could potentially enhance production of heat-induced heat-shock proteins that may contribute to certain mechanisms in the development of thermotolerance. Comparative studies indicated that the thermal enhancement of MMC cytotoxicity is marked and that the development of thermotolerance was partially inhibited by MMC. An interesting observation is that the cytotoxicity of some drugs is enhanced by mild hyperthermia. These findings are significant in the use of chemotherapy together with mild hyperthermia, which can avoid potential heat-induced normal tissue damage following local or regional hyperthermia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Johnson HA, Pavelec M (1973) Thermal enhancement of thio-TEPA cytotoxicity. J Natl Cancer Inst 50: 903–908
Hahn GM, Braun J, Har-Kedar I (1975) Thermochemotherapy: synergism between hyperthermia (42–43°C) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72: 937–940
Hahn GM, Strande DP (1976) Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst 57: 1063–1067
Engelhardt R (1987) Hyperthermia and drugs. Recent Results Cancer Res 104: 136–203
Urano M (1994) Thermochemotherapy: from in vitro and in vivo experiments to potential clinical application. In: Urano M, Douple EB (eds) Hyperthermia and oncology. VSP, Utrecht, pp 169–204
Kawahara K, Kano E (1994) Enhancement of cytotoxic effects of chemotherapeutic agents in vitro and in vivo antibiotics. In: Urano M, Douple EB (eds) Hyperthermia and oncology. VSP, Utrecht, pp 55–69
Kano E, Nitta K, Hayashi S, et al (1998) Effect of benzaldehyde on survivals of Chinese hamster V-79 cells in vitro from the combined treatment with hyperthermia. Jpn J Hyperthermic Oncol 14: 125–129
Gerner EW, Schneider MJ (1975) Induced thermal resistance in HeLa cells. Nature (Lond) 256: 500–502
Woodhall B, Pickrell KL, Georgiade NG, et al (1960) Effect of hyperthermia upon cancer chemotherapy: application to external cancers of head and face structures. Ann Surg 151: 750–759
Stehlin JS (1969) Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynecol Obstet 129: 305–308
Dickson JA, Suzanger M (1974) In vitro-in vivo studies on the susceptibility of solid Yoshida sarcoma to drug and hyperthermia (42 degrees C). Cancer Res 34: 1263–1274
Hahn GM (1978) Interaction of drugs and hyperthermia in vitro and in vivo. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban and Schwarzenberg, Baltimore, pp 72–79
Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cisdichlorodiammineplatinum (II) and mitomycin C. Cancer Res 40: 1165–1168
Roberts JJ, Friedlos F (1982) The frequency of inter-strand cross-links in DNA following reaction of cis-diamminedichloroplatinum (II) with cells in culture or DNA in vitro: stability of DNA cross-links and their repair. Chem-Biol Interact 39: 181–189
Knox RJ, Friedlos F, Lydall D, et al (1986) Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum (II) and cis-diammine(1,1-cyclobutanedicarboxylate) platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res 46:1972–1979
Meyn RE, Corry PM, Fletcher SE, et al (1980) Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum ( II ). Cancer Res 40: 1136–1139
Ohtsubo T, Chang SW, Tsuji K, et al (1990) Effects of cisdiamminedichloroplatinum (CDDP) and cis-diammine(1,1-cyclobutanedicarboxylate) platinum ( CBDCA) on thermotolerance development and thermosesitivity of the thermotolerant cells. Int J Hyperthermia 6: 1031–1039
Ohtsubo T, Saito H, Matsumoto H, et al (1997) In vitro effects of hyperthermia combined with cisplatin or peplomycin on the human maxillary carcinoma cell line IMC-2. Int J Hyperthermia 13: 59–67
Neilan BA, Henle KJ, Nagle WA, et al (1986) Cytotoxicity of hyperthermia combined with bleomycin or cis-platinum in cultured RIF cells: modification by thermotolerance and by polyhydroxy compounds. Cancer Res 46: 2245–2247
Carper SW, Duffy JJ, Gerner EW (1987) Heat shock proteins in thermotolerance and other cellular processes. Cancer Res 47: 5249–5255
Liu RY, Li X, Li L, et al (1992) Expression of human hsp70 in rat fibroblasts enhances cell survival and facilitates recovery from translational and transcriptional inhibition following heat shock. Cancer Res 52: 3667–3673
Ohtsuka K,Utsumi KR, Kaneda T, et al (1993) Effect of ATP on the release of hsp70 and hsp40 from the nucleus in heat-shocked Hela cells. Exp Cell Res 209: 357–366
Matsumoto H, Hayashi S, Shioura H, et al (1998) Suppression of heat-induced HSF activation by CDDP in human glioblastoma cells. Int J Radiat Oncol Biol Phys 41: 915–920
Terasima T, Yasukawa M, Umezawa H (1970) Breaks and rejoining of DNA in cultured mammalian cells treated with bleomycin. Gann 61: 513–516
Braun J, Hahn GM (1975) Enhanced cell killing by bleomycin and 43°C hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res 35: 2921–2927
Mizuno S, Ishida A (1981) Potentiation of bleomycin cytotoxicity toward cultured mouse cells by hyperthermia and ethanol Gann 72: 395–402
Shioura H, Hayashi S, Matsumoto H, et al (1997) The effects of combined treatments with low hyperthermia and bleomycin on survivals of murine L cells. J Exp Clin Cancer Res 16: 147–152
Kano E, Furukawa-Furuya M, Nitta K, et al (1988) Sensitivities of bleomycin-resistant variant cells enhanced by 40°C hyperthermia in vitro. Int J Hyperthermia 4: 547–553
Blum RH, Carter SK (1974) Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med 80: 249–259
Bachur NR, Gordon SL, Gee MV (1978) A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38: 1745–1752
Tewey KM, Chen GL, Nelson EM, et al (1984) Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259: 9182–9187
Dahl O (1983) Hyperthermia potentiation of doxorubicin and 4’-epidoxorubicin in a transplantable neurogenic rat 9: 203–207
Overgaard J (1976) Combined adriamycin and hyper thermia treatment of a murine mammary carcinoma in vivo. Cancer Res 36: 3077–3081
Magin RL (1983) Hyperthermia and chemotherapy: when will they be used in the clinical treatment of cancer? Eur J Cancer Clin Oncol 19: 1655–1658
Landry J, Chretein P, Lamsert H, et al (1989) Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109: 7–15
Huber SA (1992) Heat-shock protein induction in adri amycin and picornavirus-infected cardiocytes. Lab Invest 67: 218–224
Clerget M, Polla BS (1990) Erythrophagocytosis induces heat shock protein synthesis by human monocytes-macrophages. Proc Natl Acad Sci USA 87: 1081–1085
Henle KJ, Dethlefsen L (1978) Heat fractionation and thermotolerance: a review. Cancer Res 38: 1843–1851
Kano E, Furuya M, Nitta K, et al (1988) Effects of anti-tumor drugs on thermotolerance development and ther- mosensitivity of thermotolerant cells. In: Kano E (ed) Current research in hyperthermia oncology. Academic Press, New York, pp 109–125
Wallner KE, Li GC (1987) Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin-C and cisplatin. Cancer Res 47: 493–495
Tanaka N, Yamagishi H, Ohkawa T, et al (1998) Effect of benzaldehyde on regrowth time of transplanted murine N-fibrosarcoma cells after the combined treatment with hyperthermia. Jpn J Hyperthermic Oncol14: 131–138
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Japan
About this chapter
Cite this chapter
Ohtsubo, T. et al. (2001). Enhancement of Cytotoxic Effects of Chemotherapeutic Agents with Hyperthermia In Vitro. In: Kosaka, M., Sugahara, T., Schmidt, K.L., Simon, E. (eds) Thermotherapy for Neoplasia, Inflammation, and Pain. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67035-3_51
Download citation
DOI: https://doi.org/10.1007/978-4-431-67035-3_51
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67037-7
Online ISBN: 978-4-431-67035-3
eBook Packages: Springer Book Archive